Neuroprotective actions of flavonoids

Current Medicinal Chemistry

Volumn 18, Issue 8, 2011, Pages 1195-1212

  Gutierrez Merino, C ^a   Lopez Sanchez, C ^b   Lagoa, R ^a,b,c   Samhan Arias, A K ^a   Bueno, C ^a   Garcia Martinez, V ^b  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b Faculty of Medicine   (Spain)

^c POLYTECHNIC INSTITUTE OF LEIRIA   (Portugal)

Author keywords

Brain; Flavonoids; Ischemiareperfusion; Molecular targets of flavonoids; Neurodegenerative diseases; Neuroprotection; Oxidative stress; Reactive oxygen species; Therapeutic potential of flavonoids

Indexed keywords

ANTHOCYANIDIN DERIVATIVE; BAICALIN; BLUEBERRY EXTRACT; CATALASE; CATECHIN; CYTOCHROME P450; EPICATECHIN; EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; GENISTEIN; GINKGO BILOBA EXTRACT; GLUTATHIONE PEROXIDASE; HESPERETIN; HYPERICUM PERFORATUM EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOFLAVONE DERIVATIVE; ISOLIQUIRITIGENIN; ISOQUERCITRIN; KAEMPFEROL; NARINGENIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCUTELLARIA BAICALENSIS EXTRACT; SUPEROXIDE DISMUTASE; TAXIFOLIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ALZHEIMER DISEASE; ANEMIA; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN EDEMA; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN REGION; CARCINOGENICITY; CELL CULTURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EXCRETION; DRUG METABOLISM; DRUG PENETRATION; DRUG STRUCTURE; ECTOPIC PREGNANCY; ENZYME INDUCTION; ENZYME INHIBITION; EXPERIMENTAL MODEL; FOOD COMPOSITION; FRUIT; GENOTOXICITY; GLUCOSE TRANSPORT; GOITER; HUMAN; HUNTINGTON CHOREA; INFERTILITY; IRON ABSORPTION; MOTOR DYSFUNCTION; MYELOID LEUKEMIA; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; NUTRIENT UPTAKE; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PARKINSON DISEASE; SIDE EFFECT; SPONTANEOUS ABORTION; THYROID CANCER; VEGETABLE;

ANIMALS; ANTIOXIDANTS; FLAVONOIDS; HUMANS; MOLECULAR STRUCTURE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 79952790418     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711795029735     Document Type: Article

References (315)

1. ladecola, C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci., 1997, 20, 132-139.
2. Sugimoto, K.; Iadecola, C. Delayed effect of administration of COX-2 inhibitor in mice with acute cerebral ischemia. Brain Res., 2003, 960, 273-276. (Pubitemid 36044587)
3. Van der Veen, R.C.; Hinton, D.R.; Incardonna, F.; Hofman, F.M. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J. Neuroimmunol., 1997, 77, 1-7. (Pubitemid 27286370)
4. Liu, D.; Ling, X.; Wen, J.; Liu, J. The role of reactive nitrogen species in secondary spinal cord injury: Formation of nitric oxide, peroxynitrite, and nitrated protein. J. Neurochem., 2000, 75, 2144-2154.
5. Bao, F.; Liu, D. Hydroxyl radicals generated in the rat spinal cord at the level produced by impact injury induce cell death by necrosis and apoptosis: Protection by a metalloporphyrin. Neuroscience, 2004, 126, 285-295. (Pubitemid 38780804)
6. Schulz, J.B.; Henshaw, D.R.; Siwek, D.; Jenkins, B.G.; Ferrante, R.J.; Cipolloni, P.B.; Kowall, N.W.; Rosen, B.R.; Beal, M.F. Involvement of free radicals in excitotoxicity in vivo. J. Neurochem., 1995, 64, 2239-2247.
7. Brouillet, E.; Jacquard, C.; Bizat, N.; Blum, D. 3-Nitropropionic acid: A mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J. Neurochem., 2005, 95, 1521-1540. (Pubitemid 41804051)
8. Cinchetti, F.; Drouin-Ouellet, J.; Gross, R.E. Environmental toxins and Parkinson's disease: What have we learned from pesticide-induced animal models? Trends. Pharmacol. Sci., 2009, 30, 475-483.
9. Lagoa, R.; Lopez-Sanchez, C.; Samhan-Arias, A.K.; Gañan, C.M.; Garcia- Martinez, V.; Gutierrez-Merino, C. Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid. J. Neurochem., 2009, 111, 473-487.
10. Olanow, C.W. A radical hypothesis for neurodegeneration. Trends Neurosci., 1993, 16, 439-444. (Pubitemid 23313517)
11. Andrus, P.K.; Fleck, T.J.; Gurney, M.E.; Hall, E.D. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem., 1998, 71, 2041-2048. (Pubitemid 28491560)
12. Beal, M.F. Energetics in the pathogenesis of neurodegenerative diseases. Trends. Neurosci., 2000, 23, 298-304. (Pubitemid 30387044)
13. Beal, M.F. Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med., 2002, 32, 797-803. (Pubitemid 34439250)
14. Gutierrez-Merino, C. In: Free Radicals in Biology and Medicine; Gutierrez- Merino, C.; Leeuwenburgh, C., Eds.; Research Signpost: Kerala, India, 2008; pp. 67-101.
15. Mao, G.D.; Poznansky, M.J. Electron spin resonance study on the permeability of superoxide radicals in lipid bilayers and biological membranes. FEBS Lett., 1992, 305, 233-236.
16. Bedard, K.; Krause, K.H. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol. Rev., 2007, 87, 245-313. (Pubitemid 46209993)
17. Martin-Romero, F.J.; Gutierrez-Martin, Y.; Henao, F.; Gutierrez-Merino, C. The NADH oxidase activity of the plasma membrane of synaptosomes is a major source of superoxide anion and is inhibited by peroxynitrite. J. Neurochem., 2002, 82, 604-614. (Pubitemid 34831498)
18. Samhan-Arias, A.; Duarte, R.; Martin-Romero, F.J.; Moura, J.J.G.; Gutierrez- Merino, C. Reduction of ascorbate free radical by the plasma membrane of synaptic terminals from rat brain. Arch. Biochem. Biophys., 2008, 469, 243-254. (Pubitemid 350298108)
19. Murphy, M.P. How mitochondria produce reactive oxygen species. Biochem. J., 2009, 417, 1-13.
20. Zimmerman, B.J.; Granger, D.N. Mechanisms of reperfusion injury. Am. J. Med. Sci., 1994, 307, 284-292. (Pubitemid 24109155)
21. Teismann, P.; Tieu, K.; Choi, D.K.; Wu, D.C.; Naini, A.; Hunot, S.; Vila, M.; Jackson-Lewis, V.; Przedborski, S. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc. Natl. Acad. Sci. USA., 2003, 100, 5473-5478. (Pubitemid 36542729)
22. Huie, R.E.; Padmaja, S. The reaction of NO with superoxide. Free Radic. Res. Commun., 1993, 18, 195-199.
23. Bolanos, J.P.; Almeida, A.; Stewart, V.; Peuchen, S.; Land, J.M.; Clark, J.B.; Heales, S.J. Nitric oxide-mediated mitochondrial damage in the brain: Mechanisms and implications for neurodegenerative diseases. J. Neurochem., 1997, 68, 2227-2240. (Pubitemid 27218141)
24. Kirsch, M.; de Groot, H. NAD(P)H, a directly operating antioxidant? FASEB J., 2001, 15, 1569-1574.
25. Arteel, G.E.; Briviba, K.; Sies, H. Protection against peroxynitrite. FEBS Lett., 1999, 445, 226-230. (Pubitemid 29117217)
26. Li, S.W.; Lin, T.S.; Minteer, S.; Burke, W.J. 3,4 Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: Possible role in Parkinson's disease pathogenesis. Brain Res. Mol. Brain Res., 2001, 93, 1-7. (Pubitemid 32786896)
27. Mattson, M.P. Modification of ion homeostasis by lipid peroxidation: Roles in neuronal degeneration and adaptive plasticity. Trends Neurosci., 1998, 21, 53-57. (Pubitemid 28078902)
28. Sharma, S.S.; Kaundal, R.K. Neuroprotective effects of 6-hydroxy-2,5,7,8- tetramethylchroman-2-carboxylic acid (Trolox), an antioxidant in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Neurol. Res., 2007, 29, 304-309. (Pubitemid 46802369)
29. Martin-Romero, F.J.; Samhan-Arias, A.K.; Garcia-Bereguiain, M.A.; Gutierrez- Merino, C. Molecular biology of mammalian AFR reductases. Recent Res. Devel. Mol. Biol., 2004, 2, 29-52.
30. Winkler, B.S.; Orselli, S.M.; Rex, T.S. The redox couple between glutathione and ascorbic acid: A chemical and physiological perspective. Free Radic. Biol. Med., 1994, 17, 333-349. (Pubitemid 24296153)
31. Mendiratta, S.; Qu, Z.C.; May, J.M. Enzyme-dependent ascorbate recycling in human erythrocytes: Role of thioredoxin reductase. Free Radic. Biol. Med., 1998, 25, 221-228. (Pubitemid 28293158)
32. Espinosa-Garcia, J.; Gutierrez-Merino, C. The trapping of the ·OH radical by coenzyme Q. A theoretical and experimental study. J. Phys. Chem. A., 2003, 107, 9712-9723.
33. Villalba, J.M.; Navas, P. Plasma membrane redox system in the control of stress induced apoptosis. Antioxid. Redox. Signal., 2000, 2, 213-230. (Pubitemid 30445934)
34. Raps, S.P.; Lai, J.C.K.; Hertz, L.; Cooper, A.J.L. Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res., 1989, 493, 398-401. (Pubitemid 19183160)
35. Grunewald, R.A. Ascorbic acid in the brain. Brain Res. Brain Res. Rev., 1993, 18, 123-133. (Pubitemid 23090014)
36. Lindenau, J.; Noack, H.; Possel, H.; Assayama, K.; Wolf, G. Cellular distribution of superoxide dismutases in the rat CNS. Glia, 2000, 29, 25-34. (Pubitemid 30031131)
37. Sugawara, T.; Lewén, A.; Gasche, Y.; Yu, F.; Chan, P.H. Overexpression of SOD1 protects vulnerable motor neurons after spinal cord injury by attenuating mitochondrial cytochrome c release. FASEB J., 2002, 16, 1997-1999.
38. Rosen, D.R.; Siddique, T.; Patterson, D.; Figlewicz, D.A.; Sapp, P.; Hentati, A.; Donaldson, D.; Goto, J.; O'Regan, J.P.; Deng, H.X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 1993, 362, 59-62. (Pubitemid 23087289)
39. Chen, J.; Berry, M.J. Selenium and selenoproteins in the brain and brain diseases. J. Neurochem., 2003, 86, 1-12. (Pubitemid 36753840)
40. Nordberg, J.; Arner, E.S.J. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med., 2001, 31, 1287-1312. (Pubitemid 33145299)
41. Wang, H.; Cheng, E.; Brooke, S.; Chang, P.; Sapolsky, R. Over-expression of antioxidant enzymes protects cultured hippocampal and cortical neurons from necrotic insults. J. Neurochem., 2003, 87, 1527-1534. (Pubitemid 38020586)
42. Bors, W.; Michel, C.; Saran, M. Flavonoid antioxidants: Rate constants for reactions with oxygen radicals. Methods Enzymol., 1994, 234, 420-429.
43. Pannala, A.S.; Rice-Evans, C.A.; Halliwell, B.; Singh, S. Inhibition of peroxynitrite- mediated tyrosine nitration by catechin polyphenols. Biochem. Biophys. Res. Commun., 1997, 232, 164-168. (Pubitemid 27211940)
44. Heijnen, C.G.; Haenen, G.R.; van Acker, F.A.; van der Vijgh, W.J.; Bast, A. Flavonoids as peroxynitrite scavengers: The role of the hydroxyl groups. Toxicol. In Vitro., 2001, 15, 3-6. (Pubitemid 32226368)
45. Williams, C.A.; Grayer, R.J. Anthocyanins and other flavonoids. Nat. Prod. Rep., 2004, 21, 539-573. (Pubitemid 39187837)
46. Veitch, N.C.; Grayer, R. J. Flavonoids and their glycosides, including anthocyanins. Nat. Prod. Rep., 2008, 25, 555-611. (Pubitemid 351728058)
47. Harborne, J.B. Nature, distribution and function of plant flavonoids. Prog. Clin. Biol. Res., 1986, 213, 15-24.
48. Bors, W.; Michel, C.; Schikora, S. Interactions of flavonoids with ascorbate and determination of their univalent redox potentials: A pulse radiolysis study. Free Radic. Biol. Med., 1995, 19, 45-52.
49. Rimbach, G.; De Pascual-Teresa, S.; Ewins, B.A.; Matsugo, S.; Uchida, Y.; Minihane, A.M.; Turner, R.; VafeiAdou, K.; Weinberg, P.D. Antioxidant and free radical scavenging activity of isoflavones metabolites. Xenobiotica, 2003, 33, 913-925. (Pubitemid 37255402)
50. Husain, S.R.; Cillard, J.; Cillard, P. Hydroxyl radical scavenging activity of flavonoids. Phytochemistry, 1987, 26, 2489-2491.
51. -. Free Radic. Biol. Med., 1991, 11, 1-8. (Pubitemid 121003906)
52. Arora, A.; Nair, M.G.; Strasburg, G.M. Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system. Free Radic. Biol. Med., 1998, 24, 1355-1363. (Pubitemid 28270336)
53. Fukumoto, L.; Mazza, G. Assessing antioxidant and prooxidant activity of phenolic compounds. J. Agric. Food Chem., 2000, 48, 3597-3604.
54. Potapovich, A.I.; Kostyuk, V.A. Comparative study of antioxidant properties and cytoprotective activity of flavonoids. Biochemistry (Mosc), 2003, 68, 514-519.
55. Santos, M.R.; Mira, L. Protection by flavonoids against the peroxinitritemediated oxidation of dihydrorhodamine. Free Radic. Biol. Med., 2004, 38, 1011-1018. (Pubitemid 39341698)
56. Justino, G.C.; Santos, M.R.; Canario, S.; Borges, C.; Florêncio, M.H.; Mira, L. Plasma quercetin metabolites: Structure-antioxidant activity relationships. Arch. Biochem. Biophys., 2004, 432, 109-121. (Pubitemid 39425034)
57. Saija, A.; Scalese, M.; Lanza, M.; Marzullo, D.; Bonina, F.; Castelli, F. Flavonoids as antioxidant agents: Importance of their interaction with biomembranes. Free Radic. Biol. Med., 1995, 19, 481-486.
58. Jovanovic, S.V.; Steenken, S.; Simic, M.G.; Hara, H. In: Flavonoids in Health and Disease; Rice-Evans, C.; Packer, L., Eds.; Marcel Dekker: New York, 1998; pp. 137-161.
59. Ross, J.A.; Kasum, C.M. Dietary flavonoids: Bioavailability, metabolic effects and safety. Ann. Rev. Nutr., 2002, 22, 19-34. (Pubitemid 35221452)
60. Schroeter, H.; Spencer, J.P.; Rice-Evans, C.; Williams, R.J. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N terminal kinase (JNK), c-Jun and caspase-3. Biochem. J., 2001, 358, 547-557. (Pubitemid 32896942)
61. Ishige, K.; Schubert, D.; Sagara, Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic. Biol. Med., 2001, 30, 433-446. (Pubitemid 32155542)
62. Samhan-Arias, A.; Martin-Romero, F.J.; Gutierrez-Merino, C. Kaempferol blocks oxidative stress in cerebellar granule cells and reveals a key role for the plasma membrane NADH oxidase activity in the commitment of apoptosis. Free Radic. Biol. Med., 2004, 37, 48-61. (Pubitemid 38746650)
63. Ramassamy, C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets. Eur. J. Pharmacol., 2006, 545, 51-64.
64. Yazawa, K.; Kihara, T.; Shen, H.; Shimmyo, Y.; Niidome, T.; Sugimoto, H. Distinct mechanisms underlie distinct polyphenol-induced neuroprotection. FEBS Lett., 2006, 580, 6623-6628. (Pubitemid 44827019)
65. Morre, D.J.; Bridge, A.; Wu, L.Y.; Morre, D.M. Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture. Biochem. Pharmacol., 2000, 60, 937-946.
66. Van Hoorn, D.E.; Nijveldt, R.J.; Van Leeuwen, P.A.; Hofman, Z.; M'Rabet, L.; De Bont, D.B.; Van Norren, K. Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids. Eur. J. Pharmacol., 2002, 451, 111-118. (Pubitemid 35253949)
67. Dreiseitel, A.; Korte, G.; Schreier, P.; Oehme, A.; Locher, S.; Domani, M.; Hajak, G.; Sand, P.G. Berry anthocyanins and their aglycones inhibit monoamine oxidases A and B. Pharmacol. Res., 2009, 59, 306-311.
68. Mulabagal, V.; Lang, G.A.; DeWitt, D.L.; Dalavoy, S.S.; Nair, M.G. Anthocyanin content, lipid peroxidation and cyclooxygenase enzyme inhibitory activities of sweet and sour cherries. J. Agric. Food Chem., 2009, 57, 1239-1246.
69. Schneider, I.; Bucar, F. Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5- lipoxygenase and 5-lipoxygenase [sol ]cyclooxygenase. Phytother. Res., 2005, 19, 81-102. (Pubitemid 40646410)
70. Kim, M.J.; Ryu, G.R.; Kang, J.H.; Sim, S.S.; Min, D.S.; Rhie, D.J.; Yoon, S.H.; Hahn, S.J.; Jeong, I.K.; Hong, K.J.; Kim, M.S.; Jo, Y.H. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by downregulation of NF-kappaB activation. Biochem. Pharmacol., 2004, 68, 1775-1785. (Pubitemid 39278500)
71. Martínez-Flores, S.; Gutiérrez-Fernández, B.; Sánchez-Campos, S.; González- Gallego, J.; Tuñón, M.J. Quercetin prevents nitric oxide production and nuclear factor kappaB activation in interleukin-1-activated rat hepatocytes. J. Nutr., 2005, 135, 1359-1365. (Pubitemid 40799596)
72. Woo, E.R.; Lee, J.Y.; Cho, I.J.; Kim, S.G.; Kang, K.W. Amentoflavone inhibits the induction of nitric oxide synthase by inhibiting NF-kappaB activation in macrophages. Pharmacol. Res., 2005, 51, 539-546.
73. Kim, D.H.; Kim, H.K.; Park, S.; Kim, J.Y.; Zou, Y.; Cho, K.H.; Kim, Y.S.; Kim, D.H.; Yu, B.P.; Choi, J.S.; Chung, H.Y. Short-term feeding of baicalin inhibits age-associated NF-kappaB activation. Mech. Ageing Dev., 2006, 127, 719-725. (Pubitemid 44188816)
74. García-Mediavilla, M.V.; Crespo, I.; Collado, P.S.; Esteller, A.; Sánchez- Campos, S.; Tuñón, M.J.; González-Gallego, J. Anti-inflammatory effect of the flavones quercetin and kaempferol in Chang Liver cells involves inhibition of inducible nitric oxide synthase, ciclooxigenase-2 and reactive Cprotein, and down-regulation of the nuclear factor kappaB pathway. Eur. J. Pharmacol., 2007, 557, 221-229. (Pubitemid 46186282)
75. Bhaskar, S.; Shalini, V.; Helen, A. Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLRNFkB signaling pathway. Immunobiology, 2010, d.o.i. 10.1016/ j.imbio.2010.07.011
76. Kim, J.; Lee, H.J.; Lee, K.W. Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J. Neurochem., 2010, 112, 1415-1430.
77. Kim, J.M.; Lee, E.K.; Park, G.; Kim, M.K.; Yokozawa, T.; Yu, B.P.; Chung, H.Y. Morin modulates the oxidative stress-induced NF-kappaB pathway through its anti-oxidant activity. Free Radic Res., 2010, 44, 454-461.
78. Manach, C.; Régérat, F.; Texier, G.; Agullo, G.; Demigné, C.; Rémésy, C. Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids. Nutr. Res., 1996, 16, 517-544. (Pubitemid 26084096)
79. Chen, I.F.; Breen, K. On the ability of four flavonoids, baicilein, luteolin, naringenin, and quercetin, to suppress the Fenton reaction of the iron-ATP complex. Biometals, 2000, 13, 77-83. (Pubitemid 30243039)
80. Rice-Evans, C. Flavonoid antioxidants. Curr. Med. Chem., 2001, 8, 797-807. (Pubitemid 32427907)
81. Mira, L.; Fernandez, M.T.; Santos, M.; Rocha, R.; Florêncio, M.H.; Jennings, K.R. Interactions of flavonoids with iron and copper ions: A mechanism for their antioxidant activity. Free Radic. Res., 2002, 36, 1199-1208. (Pubitemid 35230240)
82. Silva, M.M.; Santos, M.R.; Caroço, G.; Rocha, R.; Justino, G.; Mira, L. Structure-antioxidant activity relationships of flavonoids: A re-examination. Free Radic. Res., 2002, 36, 1219-1227. (Pubitemid 35230242)
83. Boyle, S.P.; Dobson, V.L.; Duthie, S.J.; Hinselwood, D.C.; Kyle, J.A.; Collins, A.R. Bioavailability and efficiency of rutin as an antioxidant: A human supplementation study. Eur. J. Clin. Nutr., 2000, 54, 774-782.
84. Huber, A.; Bürkle, A.; Münch, G. In: Handbook of Neurochemistry and Molecular Neurobiology. Degenerative Diseases of the Nervous System; Lajtha, A.Y.; Riederer, P.; Mandel, S.A.; Battistin, L., Eds.; Springer-Verlag: Berlin, Germany, 2007; pp. 77-102.
85. Dunnick, J. K.; Hailey, J.R. Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fundam. Appl. Toxicol., 1992, 19, 423-431.
86. Galati, G.; Sabzevari, O.; Wilson, J.X.; O'Brien, P.J. Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and the other polyphenolics. Toxicology, 2002, 177, 91-104. (Pubitemid 34786247)
87. Jeong, J.M.; Choi, C.H.; Kang, S.K.; Lee, I.H.; Lee, J.Y.; Jung, H. Antioxidant and chemosensitizing effects of flavonoids with hydroxy and/or methoxy groups and structure-activity relationship. J. Pharm. Pharm. Sci., 2007, 10, 537-546.
88. Galati, G.; Moridani, M.Y.; Chan, T.S.; O'Brien, P.J. Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: Glutathione oxidation and conjugation. Free Radic. Biol. Med., 2001, 30, 370-382. (Pubitemid 32155536)
89. Metodiewa, D.; Jaiswal, A.K.; Cenas, N.; Dickancaité, E.; Segura-Aguilar, J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic. Biol. Med., 1999, 26, 107-116. (Pubitemid 29001498)
90. Wells, W.W.; Xu, D.P. Dehydroascorbate reduction. J. Bioenerg. Biomembr., 1994, 26, 369-377. (Pubitemid 24321062)
91. Boots, A.W.; Li, H.; Schins, R.P.F.; Duffin, R.; Heemskerk, J.W.M.; Bast, A.; Haenen, G.R.M.M. The quercetin paradox. Toxicol. Appl. Pharmacol., 2007, 222, 89-96. (Pubitemid 46962659)
92. Walle, T. Absorption and metabolism of flavonoids. Free Radic. Biol. Med., 2004, 36, 829-837. (Pubitemid 38401062)
93. Kuhnle, G.; Spencer, J.P.E.; Schroeter, H.; Shenoy, B.; Debnam, E.S.; Srai, S.K.S.; Rice-Evans, C.; Hahn, U. Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochem. Biophys. Res. Commun., 2000, 277, 507-512.
94. Donovan, J.L.; Bell, J.R.; Kasim-Karakas, S.; German, J.B.; Walzern, R.L.; Hansen, R.J.; Waterhouse, A.L. Catechin is present as metabolites in human plasma after consumption of red wine. J. Nutr., 1999, 129, 1662-1668. (Pubitemid 29406618)
95. Moon, J.H.; Nakata, R.; Oshima, S.; Inakuma, T.; Terao, J. Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2000, 279, R461-R467.
96. Graefe, E.U.; Wittig, J.; Mueller, S.; Riethling, A.K.; Uehleke, B.; Drewelow, B.; Pforte, H.; Jacobasch, G.; Derendorf, H.; Veit, M. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol., 2001, 41, 492-499. (Pubitemid 32381866)
97. Day, A.J.; Mellon, F.; Barron, D.; Sarrazin, G.; Morgan, M.R.A.; Williamson, G. Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin. Free Rad. Res., 2001, 35, 941-952. (Pubitemid 34065683)
98. Santos, M.R.; Rodríguez-Gómez, M.J.; Justino, G.C.; Charro, N.; Florencio, M.H.; Mira, L. Influence of the metabolic profile on the in vivo antioxidant activity of quercetin under a low dosage oral regimen in rats. Br. J. Pharmacol., 2008, 153, 1750-1761. (Pubitemid 351536003)
99. Spencer, J.P.E.; Kuhnle, G.G.C.; Williams, R.J.; Rice-Evans, C. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem. J., 2003, 372, 173-181. (Pubitemid 36609619)
100. Spencer, J.P.E.; Abd El Mohsen, M.M.; Rice-Evans, C. Cellular uptake and metabolism of flavonoids and their metabolites: Implications for their bioactivity. Arch. Biochem. Biophys., 2004, 423, 148-161. (Pubitemid 38198224)
101. Vafeiadou, K.; Vauzour, D.; Rodriguez-Mateos, A.; Whiteman, M.; Williams, R.J.; Spencer, J.P.E. Glial metabolism of quercetin reduces its neurotoxic potential. Arch. Biochem. Biophys., 2008, 478, 195-200.
102. Manach, C.; Morand, C.; Crespy, V.; Demigné, C.; Texier, O.; Régérat, F.; Rémésy, C. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett., 1998, 426, 331-336. (Pubitemid 28218374)
103. Yamamoto, N.; Moon, J.H.; Tsushida, T.; Nagao, A.; Terao, J. Inhibitory effect of quercetin metabolites and their related derivatives on copper ioninduced lipid peroxidation in human low-density lipoprotein. Arch. Biochem. Biophys., 1999, 372, 347-354. (Pubitemid 30026786)
104. Moon, J.H.; Tsushida, T.; Nakahara, K.; Terao, J. Identification of quercetin 3-O-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. Free Radic. Biol. Med., 2001, 30, 1274-1285. (Pubitemid 32463938)
105. Spencer, J.P.E.; Schroeter, H.; Crossthwaithe, A.J.; Kuhnle, G.; Williams, R.J.; Rice-Evans, C. Contrasting influences of glucuronidation and Omethylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts. Free Radic. Biol. Med., 2001, 31, 1139-1146. (Pubitemid 33000135)
106. Pollard, S.E.; Kuhnle, G.G.C.; Vauzour, D.; Vafeiadou, K.; Tzounis, X.; Whiteman, M.; Rice-Evans, C.; Spencer, J.P.E. The reaction of flavonoid metabolites with peroxynitrite. Biochem. Biophys. Res. Commun., 2006, 350, 960-968. (Pubitemid 44584186)
107. Lodi, F.; Jimenez, R.; Moreno, L.; Kroon, P.A.; Needs, P.W.; Hughes, D.A.; Santos-Buelga, C.; Gonzalez-Paramas, A.; Cogolludo, A.; Lopez-Sepulveda, R.; Duarte, J.; Perez-Vizcaino, F. Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis, 2009, 204, 34-39.
108. Koga, T.; Meydani, M. Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am. J. Clin. Nutr., 2001, 73, 941-948. (Pubitemid 32405992)
109. Steffen, Y.; Gruber, C.; Schewe, T.; Sies, H. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch. Biochem. Biophys., 2008, 469, 209-219. (Pubitemid 50008450)
110. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Rémésy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr., 2005, 81, 230S-242S.
111. Williamson, G.; Manach, C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr., 2005, 81, 243S-255S.
112. Schroeter, H.; Williams, R.J.; Matin, R.; Iversen, L.; Rice-Evans, C.A. Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein. Free Radic. Biol. Med., 2000, 29, 1222-1233.
113. Areias, F.M.; Rego, A.C.; Oliveira, C.R.; Seabra, R.M. Antioxidant effect of flavonoids after ascorbate/Fe(2+)-induced oxidative stress in cultured retinal cells. Biochem. Pharmacol., 2001, 62, 111-118. (Pubitemid 32488982)
114. Abbott, N.J.; Patabendige, A.A.K.; Dolman, D.E.M.; Yusof, S.R.; Begley, D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis., 2010, 37, 13-25.
115. Suganuma, M.; Okabe, S.; Oniyama, M.; Tada, Y.; Ito, H.; Fujiki, H. Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis, 1998, 19, 1771-1776. (Pubitemid 28476352)
116. Abd El Mohsen, M.M.; Kuhnle, G.; Rechner, A.R.; Schroeter, H.; Rose, S.; Jenner, P.; Rice-Evans, C.A. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic. Biol. Med., 2002, 33, 1693-1702. (Pubitemid 35462009)
117. Huang, H.; Zhang, Y.; Yang, R.; Tang, X. Determination of baicalin in rat cerebrospinal fluid and blood using microdialysis coupled with ultra performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 2008, 874, 77-83.
118. Peng, H.W.; Cheng, F.C.; Huang, Y.T.; Chen, C.F.; Tsai, T.H. Determination of naringenin and its glucuronide conjugate in rat plasma and brain tissue by high-performance liquid chromatography. J. Chromatogr. B. Biomed. Sci. Appl., 1998, 714, 369-374. (Pubitemid 28386860)
119. Tsai, T.H.; Chen, Y.F. Determination of unbound hesperetin in rat blood and brain by microdialysis coupled to microbore liquid chromatography. J. Food Drug Anal., 2000, 8, 331-336.
120. Paulke, A.; Schubert-Zsilavecz, M.; Wurglics, M. Determination of St. John's wort flavonoid-metabolites in rat brain through high performance liquid chromatography coupled with fluorescence detection. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 2006, 832, 109-113. (Pubitemid 43213017)
121. Talavera, S.; Felgines, C.; Texier, O.; Besson, C.; Gil-Izquierdo, A.; Lamaison, J.L.; Rémésy, C. Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain. J. Agric. Food Chem., 2005, 53, 3902-3908. (Pubitemid 40936741)
122. Andres-Lacueva, C.; Shukitt-Hale, B.; Galli, R.L.; Jauregui, O.; Lamuela-Raventos, R.M.; Joseph, J.A. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr. Neurosci., 2005, 8, 111-120. (Pubitemid 40959652)
123. Kalt, W.; Blumberg, J.B.; McDonald, J.E.; Vinqvist-Tymchuk, M.R.; Fillmore, S.A.E.; Graf, B.A.; O'Leary, J.M.; Milbury, P.E. Identification of anthocyanins in the liver, eye, and brain of blueberry-fed pigs. J. Agric. Food Chem., 2008, 56, 705-712. (Pubitemid 351300234)
124. Zini, A.; Del Rio, D.; Stewart, A.J.; Mandrioli, J.; Merelli, E.; Sola, P.; Nichelli, P.; Serafini, M.; Brighenti, F.; Edwards, C.A.; Crozier, A. Do flavan-3-ols from green tea reach the human brain? Nutr. Neurosci., 2006, 9, 57-61. (Pubitemid 44057031)
125. Youdim, K.A.; Dobbie, M.S.; Kuhnle, G.; Proteggente, A.R.; Abbott, N.J.; Rice-Evans, C. Interaction between flavonoids and the blood-brain barrier: In vitro studies. J. Neurochem., 2003, 85, 180-192. (Pubitemid 36389708)
126. Youdim, K.A.; Qaiser, M.Z.; Begley, D.J.; Rice-Evans, C.A.; Abbott, N.J. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic. Biol. Med., 2004, 36, 592-604. (Pubitemid 38230176)
127. Bansal, T.; Jaggi, M.; Khar, R.K.; Talegaonkar, S. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. J. Pharm. Pharm. Sci., 2009, 12, 46-78.
128. Alvarez, A.I.; Real, R.; Pérez, M.; Mendoza, G.; Prieto, J.G.; Merino, G. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. J. Pharm. Sci., 2010, 99, 598-617.
129. Dreiseitel, A.; Oosterhuis, B.; Vukman, K.V.; Schreier, P.; Oehme, A.; Locher, S.; Hajak, G.; Sand, P.G. Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1. Br. J. Pharmacol., 2009, 158, 1942-1950.
130. O'Leary, K.A.; Day, A.J.; Needs, P.W.; Sly, W.S.; O'Brien, N.M.; Williamson, G. Flavonoid glucuronides are substrates for human liver - glucuronidase. FEBS Lett., 2001, 503, 103-106. (Pubitemid 32769964)
131. Sperker, B.; Backman, J.T.; Kroemer, H.K. The role of β-glucuronidase in drug disposition and drug targeting in humans. Clin. Pharmacokinet., 1997, 33, 18-31. (Pubitemid 27303115)
132. Tukey, R.H.; Strassburg, C.P. Human UDP-glucuronosyltransferases: Metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol., 2000, 40, 581-616. (Pubitemid 30340694)
133. Shimoi, K.; Saka, N.; Nozawa, R.; Sato, M.; Amano, I.; Nakayama, T.; Kinae, N. Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metab. Dispos., 2001, 29, 1521-1524. (Pubitemid 33111582)
134. Kawai, Y.; Nishikawa, T.; Shiba, Y.; Saito, S.; Murota, K.; Shibata, N.; Kobayashi, M.; Kanayama, M.; Uchida, K.; Terao, J. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: Implication in the antiatherosclerotic mechanism of dietary flavonoids. J. Biol. Chem., 2008, 283, 9424-9434.
135. Triggiani, M.; Gentile, M.; Secondo, A.; Granata, F.; Oriente, A.; Taglialatela, M.; Annunziato, L.; Marone, G. Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J. Immunol., 2001, 166, 4083-4091. (Pubitemid 32224939)
136. Palmer, A.M. The role of the blood-CNS barrier in CNS disorders and their treatment. Neurobiol. Dis., 2010, 37, 3-12.
137. Ohnishi, T.; Tamai, I.; Sakanaka, K.; Sakata, A.; Yamashima, T.; Yamashita, J.; Tsuji, A. In vivo and in vitro evidence for ATP-dependency of Pglycoprotein- mediated efflux of doxorubicin at the blood-brain barrier. Biochem. Pharmacol., 1995, 49, 1541-1544.
138. Hartings, J.A.; Rolli, M.L.; Lu, X.C.M.; Tortella, F.C. Delayed secondary phase of peri-infarct depolarizations after focal cerebral ischemia: Relation to infarct growth and neuroprotection. J. Neurosci., 2003, 23, 11602-11610. (Pubitemid 38021287)
139. Hossmann, K.A. Pathophysiology and therapy of experimental stroke. Cell. Mol. Neurobiol., 2006, 26, 1057-1083.
140. Chan, P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab., 2001, 21, 2-14. (Pubitemid 32036708)
141. Saito, A.; Hayashi, T.; Okuno, S.; Nishi, T.; Chan, P.H. Oxidative stress is associated with XIAP and Smac/DIABLO signaling pathways in mouse brains after transient focal cerebral ischemia. Stroke, 2004, 35, 1443-1448. (Pubitemid 38697473)
142. Romanic, A.M.; White, R.F.; Arleth, A.J.; Ohlstein, E.H.; Barone, F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: Inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke, 1998, 9, 1020-1030. (Pubitemid 28228167)
143. Heo, J.H.; Lucero, J.; Abumiya, T.; Koziol, J.A.; Copeland, B.R.; del Zoppo, G.J. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab., 1999, 19, 624-633. (Pubitemid 30161214)
144. Asahi, M.; Asahi, K.; Jung, J.C.; del Zoppo, G.J.; Fini, M.E.; Lo, E.H. Role for matrix metalloproteinase 9 after focal cerebral ischemia. Effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab., 2000, 20, 1681-1689.
145. Gu, Z.Z.; Cui, J.; Brown, S.; Fridman, R.; Mobashery, S.; Strongin, A.Y.; Lipton, S.A. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J. Neurosci., 2005, 25, 6401-6408. (Pubitemid 40962536)
146. Krajewski, S.; Krajewska, M.; Ellerby, L.M.; Welsh, K.; Xie, Z.H.; Deveraux, Q.L.; Salvesen, G.S.; Bredesen, D.E.; Rosenthal, R.E.; Fiskum, G.; Reed, J.C. Release of caspase-9 from mitochondria during neuronal apoptosis and
147. Cao, G.; Luo, Y.; Nagayama, T.; Pei, W.; Stetler, R.A.; Graham, S.H.; Chen, J. Cloning and characterization of rat caspase-9: Implications for a role in mediating caspase-3 activation and hippocampal cell death after transient cerebral ischemia. J. Cereb. Blood Flow Metab., 2002, 22, 534-546. (Pubitemid 34477775)
148. Cho, S.; Liu, D.; Gonzales, C.; Zaleska, M.M.; Wood, A. Temporal assessment of caspase activation in experimental models of focal and global ischemia. Brain Res., 2003, 982, 146-155. (Pubitemid 37281412)
149. Feng, G.L.; Tang, Y.Z.; Dun, W.; Wang, Z.P. Protection of methylflavonolamine against acute cerebral ischemia reperfusion injury in rats. Zhongguo Yao Li Xue Bao, 1995, 16, 304-307.
150. Shutenko, Z.; Henry, Y.; Pinard, E.; Seylaz, J.; Potier, P.; Berthet, F.; Girard, P.; Sercombe, R. Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion. Biochem. Pharmacol., 1999, 57, 199-208. (Pubitemid 29056182)
151. Li, H.; Zhang, G.Y. Inhibitory effect of genistein on activation of STAT3 induced by brain ischemia/reperfusion in rat hippocampus. Acta Pharmacol. Sinica., 2003, 24, 1131-1174.
152. Sarkar, S.; Das, N. Mannosylated liposomal flavonoid in combating agerelated ischemia-reperfusion induced oxidative damage in rat brain. Mech. Ageing Dev., 2006, 127, 391-397. (Pubitemid 43290543)
153. Shang, Y.; Cheng, J.; Qi, J.; Miao, H. Scutellaria flavonoid reduced memory dysfunction and neuronal injury caused by permanent global ischemia in rats. Pharmacol. Biochem. Behav., 2005, 82, 67-73. (Pubitemid 41423488)
154. Shang, Y.Z.; Miao, H.; Cheng, J.J.; Qi, J.M. Effects of amelioration of total flavonoids from stems and leaves of Scutellaria baicalensis Georgi on cognitive deficits, neuronal damage and free radicals disorder induced by cerebral ischemia in rats. Biol. Pharm. Bull., 2006, 29, 805-810.
155. Pu, F.L.; Mishima, K.; Irie, K.; Motohashi, K.; Tanaka, Y.; Orito, K.; Egawa, T.; Kitamura, Y.; Egashira, N.; Iwasaki, K.; Fujiwara, M. Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. J. Pharmacol. Sci., 2007, 104, 329-334. (Pubitemid 47378420)
156. Sutherland, B.A.; Shaw, O.M.; Clarkson, A.N.; Jackson, D.M.; Sammut, I.A.; Appleton, I. Neuroprotective effects of (-)-epigallocatechin gallate following hypoxia/ischemia-induced brain damage: Novel mechanisms of action. FASEB J., 2005, 19, 258-260. (Pubitemid 40189274)
157. Lin, X.J.; Yang, Y.J.; Qi, B.X.; Wang, X.; Song, J.H. Protective effects of baicalin pretreatment on hypoxic-ischemic brain damage in neonatal rats. Chin. J. Pediatrics., 2006, 8, 221-224. (Pubitemid 43965092)
158. Shin, D.H.; Bae, Y.C.; Kim-Han, J.S.; Lee, J.H.; Choi, I.Y.; Son, K.H.; Kang, S.S.; Kim, W.K.; Han, B.H. Polyphenol amentoflavone affords neuroprotection against neonatal hypoxic-ischemic brain damage via multiple mechanisms. J. Neurochem., 2006, 96, 561-572.
159. Dajas, F.; Rivera, F.; Blasina, F.; Arredondo, F.; Echeverry, C.; Lafon, L.; Morquio, A.; Heizen, H. Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotox. Res., 2003, 5, 425-432.
160. Cho, J.; Lee, H.K. Wogonin inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Biol. Pharm. Bull., 2004, 27, 1561-1564. (Pubitemid 41701639)
161. Rivera, F.; Urbanavicius, J.; Gervaz, E.; Morquio, A.; Dajas, F. Some aspects of the in vivo neuroprotective capacity of flavonoids: Bioavailability and structure-activity relationship. Neurotox. Res., 2004, 6, 543-553.
162. Li, R.P.; Guo, M.L.; Zhang, G.; Xu, X.F.; Li, Q. Neuroprotection of nicotiflorin in permanent focal cerebral ischemia and in neuronal cultures. Biol. Pharm. Bull., 2006, 29, 1868-1872. (Pubitemid 44338409)
163. Hong, J.T.; Ryu, S.R.; Kim, H.J.; Lee, J.K.; Lee, S.H.; Kim, D.B.; Yun, Y.P.; Ryu, J.H.; Lee, B.M.; Kim, P.Y. Neuroprotective effect of green tea extract in experimental ischemia-reperfusion brain injury. Brain Res. Bull., 2000, 53, 743-749. (Pubitemid 32120278)
164. Hwang, Y.S.; Shin, C.Y.; Huh, Y.; Ryu, J.H. Hwangryun-Hae-Dok-tang (Huanglian-Jie-Du-Tang) extract and its constituents reduce ischemiareperfusion brain injury and neutrophil infiltration in rats. Life Sci., 2002, 71, 2105-2117.
165. Choi, Y.B.; Kim, Y.I.; Lee, K.S.; Kim, B.S.; Kim, D.J. Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats. Brain Res., 2004, 1019, 47-54. (Pubitemid 39078609)
166. Suzuki, M.; Tabuchi, M.; Ikeda, M.; Umegaki, K.; Tomita, A. Protective effects of green tea catechins on cerebral ischemic damage. Med. Sci. Monit., 2004, 10, BR166-174. (Pubitemid 38878775)
167. Hu, X.M.; Zhou, M.M.; Hu, X.M.; Zeng, F.D. Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion. Acta Pharmacol. Sin., 2005, 26, 1454-1459.
168. Rahman, R.M.A.; Nair, S.M.; Helps, S.C.; Shaw, O.M.; Sims, N.R.; Rosengren, R.J.; Appleton, I. (-)-Epigallocatechin gallate as an intervention for the acute treatment of cerebral ischemia. Neurosci. Lett., 2005, 382, 227-230. (Pubitemid 40733627)
169. Zhang, Z.J.; Wang, Z.; Zhang, X.Y.; Ying, K.; Liu, J.X.; Wang, Y.Y. Gene expression profile induced by oral administration of baicalin and gardenin after focal brain ischemia in rats. Acta Pharmacol. Sin., 2005, 26, 307-314. (Pubitemid 40388066)
170. Li, R.P.; Guo, M.L.; Zhang, G.; Xu, X.F.; Li, Q. Nicotiflorin reduces cerebral ischemic damage and upregulates endothelial nitric oxide synthase in primarily cultured rat cerebral blood vessel endothelial cells. J. Ethnopharmacol., 2006, 107, 143-150. (Pubitemid 44038823)
171. Shin, W.H.; Park, S.J.; Kim, E.J. Protective effect of anthocyanins in middle cerebral artery occlusion and reperfusion model of cerebral ischemia in rats. Life Sci., 2006, 79, 130-137.
172. Wang, P.Y.; Wang, H.P.; Li, G.W. Protective effect of pueraria flavonoid on the cerebral ischemic reperfusion injury in rats. Zhongguo Zhong Yao Za Zhi, 2006, 31, 577-579.
173. Wang, Y.H.; Wang, W.Y.; Chang, C.C.; Liou, K.T.; Sung, Y.J.; Liao, J.F.; Chen, C.F.; Chang, S.; Hou, Y.C.; Chou, Y.C.; Shen, Y.C. Taxifolin ameliorates cerebral ischemia-reperfusion injury in rats through its anti-oxidative effect and modulation of NF-kappa B activation. J. Biomed. Sci., 2006, 13, 127-141. (Pubitemid 43162511)
174. Zhan, C.; Yang, J. Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol. Res., 2006, 53, 303-309. (Pubitemid 43247544)
175. Zhang, Y.; Wang, X.; Wang, X.; Xu, Z.; Liu, Z.; Ni, Q.; Chu, X.; Qiu, M.; Zhao, A.; Jia, W. Protective effect of flavonoids from Scutellaria baicalensis Georgi on cerebral ischemia injury. J. Ethnopharmacol., 2006, 108, 355-360. (Pubitemid 44693103)
176. Zhang, Z.J.; Wang, L.Y.; Wang, Z.; Li, P.T.; Wang, Y.Y. Pharmacological evaluation of baicalin and jasminoidin and their combination on focal cerebral ischemia-reperfusion injury. Zhongguo Zhong Yao Za Zhi., 2006, 31, 907-910.
177. Lopez-Sanchez, C.; Martin-Romero, F.J.; Sun, F.; Luis, L.; Samhan-Arias, A.K.; Garcia-Martinez, V.; Gutierrez-Merino, C. Blood micromolar concentrations of kaempferol afford protection against ischemia/reperfusioninduced damage in rat brain. Brain Res., 2007, 1182, 123-137. (Pubitemid 350086989)
178. Lin, L.L.; Liu, A.J.; Liu, J.G.; Yu, X.H.; Qin, L.P.; Su, D.F. Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats. J. Cardiovasc. Pharmacol., 2007, 50, 327-332.
179. Yu, X.Q.; Xue, C.C.; Zhou, Z.W.; Li, C.G.; Du, Y.M.; Liang, J.; Zhou, S.F. In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice). Life Sci., 2008, 82, 68-78. (Pubitemid 350251394)
180. Cho, J.Y.; Kim, I.S.; Jang, Y.H.; Kim, A.R.; Lee, S.R. Protective effect of quercetin, a natural flavonoid against neuronal damage after transient global cerebral ischemia. Neurosci. Lett., 2006, 404, 330-335.
181. Li, L.; Zhou, Q.X.; Shi, J.S. Protective effects of icariin on neurons injured by cerebral ischemia/reperfusion. Chin. Med. J., 2005, 118, 1637-1643. (Pubitemid 41489040)
182. Matsuoka, Y.; Hasegawa, H.; Okuda, S.; Muraki, T.; Uruno, T.; Kubota, K. Ameliorative effects of tea catechins on active oxygen-related nerve cell injuries. J. Pharmacol. Exp. Ther., 1995, 274, 602-608.
183. Weng, H.B.; Ma, T.; Liu, Y.L. Protective effect of daidzein on cerebral ischemia and its mechanism. Chinese Pharmacol. Bull., 1999, 15, 534.
184. Kang, T.H.; Hur, J.Y.; Kim, H.B.; Ryu, J.H.; Kim, S.Y. Neuroprotective effects of the cyanidin-3-O-beta-D-glucopyranoside isolated from mulberry fruit against cerebral ischemia. Neurosci. Lett., 2006, 391, 122-126.
185. Ha, S.K.; Lee, P.; Park, J.A.; Oh, H.R.; Lee, S.Y.; Park, J.H.; Lee, E.H.; Ryu, J.H.; Lee, K.R.; Kim, S.Y. Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion- induced focal ischemia mice model. Neurochem. Int., 2008, 52, 878-886.
186. Inanami, O.; Watanabe, Y.; Syuto, B.; Nakano, M.; Tsuji, M.; Kuwabara, M. Oral administration of (-)catechin protects against ischemia-reperfusioninduced neuronal death in the gerbil. Free Radic. Res., 1998, 29, 359-365. (Pubitemid 29027456)
187. Lee, S.R.; Suh, S.I.; Kim, S.P. Protective effects of the green tea polyphenol (-)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci. Lett., 2000, 287, 191-104.
188. Hong, J.T.; Ryu, S.R.; Kim, H.J.; Lee, J.K.; Lee, S.H.; Yun, Y.P.; Lee, B.M.; Kim, P.Y. Protective effect of green tea extract on ischemia/ reperfusioninduced brain injury in Mongolian gerbils. Brain Res., 2001, 888, 11-18. (Pubitemid 32056258)
189. Lee, S.Y.; Kim, C.Y.; Lee, J.J.; Jung, J.G.; Lee, S.R. Effects of delayed administration of (-)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils. Brain Res. Bull., 2003, 61, 399-406.
190. Zhang, D.L.; Zhang, Y.T.; Yin, J.J.; Zhao, B.L. Oral administration of Crataegus flavonoids protects against ischemia/reperfusion brain damage in gerbils. J. Neurochem., 2004, 90, 211-219.
191. Lee, H.; Bae, J.H.; Lee, S.R. Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. J. Neurosci. Res., 2004, 77, 892-900. (Pubitemid 39187072)
192. Nagai, K.; Jiang, M.H.; Hada, J.; Nagata, T.; Yajima, Y.; Yamamoto, S.; Nishizaki, T. (-)-Epigallocatechin gallate protects against NO stress-induced neuronal damage after ischemia by acting as an anti-oxidant. Brain Res., 2002, 956, 319-322. (Pubitemid 35351399)
193. Wei, I.H.; Wu, Y.C.; Wen, C.Y.; Shieh, J.Y. Green tea polyphenol (-)- epigallocatechin gallate attenuates the neuronal NADPH-d/nNOS expression in the nodose ganglion of acute hypoxic rats. Brain Res., 2004, 999, 73-80.
194. Liu, C.; Tu, F.X.; Chen, X. Neuroprotective effects of apigenin on acute transient focal cerebral ischemia-reperfusion injury in rats. Zhong Yao Cai., 2008, 31, 870-873.
195. Li, H.; Wang, H.; Chen, J.H.; Wang, L.H.; Zhang, H.S.; Fan, Y. Determination of amino acid neurotransmitters in cerebral cortex of rats administered with baicalin prior to cerebral ischemia by capillary electrophoresis-laserinduced fluorescence detection. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 2003, 788, 93-101. (Pubitemid 36369114)
196. Wang, Z.; Ying, K.; Zhang, Z.J.; Liu, J.X.; Zhang, X.Y.; Xu, L.; Wei, C.E.; Huang, Y.; Wang, Y.Y. The effect of baicalin on gene expression profile in rat brain of focal cerebral ischemia. Zhongguo Zhong Yao Za Zhi., 2004, 29, 83-86.
197. Sun, F.; Lopez-Sanchez, C.; Martin-Romero, F.J.; Luis, L.; Gutierrez- Merino, C.; Garcia-Martinez, V. Transfemoral selective "intraluminal wiring" technique for transient middle cerebral artery occlusion in rats. J. Neurosci. Methods., 2005, 149, 82-89. (Pubitemid 41606021)
198. Saleem, S.; Zhuang, H.; Biswal, S.; Christen, Y.; Doré, S. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke, 2008, 39, 3389-3396.
199. Hong, J.T.; Yen, J.H.; Wang, L.; Lo, Y.H.; Chen, Z.T.; Wu, M.J. Regulation of heme oxygenase-1 expression and MAPK pathways in response to kaempferol and rhamnocitrin in PC12 cells. Toxicol. Appl. Pharmacol., 2009, 237, 59-68.
200. Gao, S.S.; Choi, B.M.; Chen, X.Y.; Zhu, R.Z.; Kim, Y.; So, H.; Park, R.; Sung, M.; Kim, B.R. Kaempferol suppresses cisplatin-induced apoptosis via inductions of heme oxygenase-1 and glutamate-cysteine ligase catalytic subunit in HEI-OC1 cells. Pharm. Res., 2010, 27, 235-245.
201. Rivera, F.; Costa, G.; Abin, A.; Urbanavicius, J.; Arruti, C.; Casanova, G.; Dajas, F. Reduction of ischemic brain damage and increase of glutathione by a liposomal preparation of quercetin in permanent focal ischemia in rats. Neurotox. Res., 2008, 13, 105-114.
202. Khan, M.; Ahmad, A.; Ishrat, T.; Khuwaja, G.; Srivastawa, P.; Khan, M.B.; Raza, S.S.; Javed, H.; Vaibhav, K.; Khan, A.; Islam, F. Rutin protects the neural damage induced by transient focal ischemia in rats. Brain Res., 2009, 1292, 123-135.
203. Gaur, V.; Aggarwal, A.; Kumar, A. Protective effect of naringin against ischemic reperfusion cerebral injury: Possible neurobehavioral, biochemical and cellular alterations in rat brain. Eur. J. Pharmacol., 2009, 616, 147-154.
204. Choi, E.J.; Ahn, W.S. Neuroprotective effects of chronic hesperetin administration in mice. Arch. Pharm. Res., 2008, 31, 1457-1462.
205. Liang, H.W.; Qiu, S.F.; Shen, J.; Sun, L.N.; Wang, J.Y.; Bruce, I.C.; Xia, Q. Genistein attenuates oxidative stress and neuronal damage following transient global cerebral ischemia in rat hippocampus. Neurosci. Lett., 2008, 438, 116-120.
206. Zhao, T.; Han, J.; Chen, Y.; Wan, H.; Bie, X. The mechanism of 3-methoxy puerarin on decreasing the cerebral ischemia-reperfusion injury in rats. Asia Pac. J. Clin. Nutr., 2007, 16, 302-304. (Pubitemid 46524619)
207. Pan, H.P.; Li, G. Protecting mechanism of puerarin on the brain neurocyte of rat in acute local ischemia brain injury and local cerebral ischemiareperfusion injury. Yakugaku Zasshi., 2008, 128, 1689-1698.
208. Gao, L.; Ji, X.; Song, J.; Liu, P.; Yan, F.; Gong, W.; Dang, S.; Luo, Y. Puerarin protects against ischemic brain injury in a rat model of transient focal ischemia. Neurol. Res., 2009, 31, 402-406.
209. Han, J.; Wan, H.; Ge, L.; Zhu, Z.; Guo, Y.; Zhang, Y.; Li, J. Protective effect of 3'-methoxy puerarin on cerebral ischemic injury/ reperfusion in rats. Zhongguo Zhong Yao Za Zhi., 2009, 34, 1422-1425.
210. Praticò, D.; Delanty, N. Oxidative injury in diseases of the central nervous system: Focus on Alzheimer's disease. Am. J. Med., 2000, 109, 577-585.
211. Boothby, L.A.; Doering, P.L. Vitamin C and vitamin E for Alzheimer's disease. Ann. Pharmacother., 2005, 39, 2073-2080.
212. Veurink, G.; Fuller, S.J.; Atwood, C.S.; Martins, R.N. Genetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease. Ann. Hum. Biol., 2003, 30, 639-667. (Pubitemid 38097890)
213. Engelhart, M.J.; Geerlings, M.I.; Ruitenberg, A.; Van Swieten, J.C.; Hofman, A.; Witteman, J.C.M.; Breteler, M.M.B. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA, 2002, 287, 3223-3229. (Pubitemid 34686103)
214. Commenges, D.; Scotet, V.; Renaud, S.; Jacqmin-Gadda, H.; Barberger- Gateau, P.; Dartigues, J.F. Intake of flavonoids and risk of dementia. Eur. J. Epidemiol., 2000, 16, 357-363. (Pubitemid 30648741)
215. Letenneur, L.; Proust-Lima, C.; Le Gouge, A.; Dartigues, J.F.; Barberger- Gateau, P. Flavonoid intake and cognitive decline over a 10-year period. Am. J. Epidemiol., 2007, 165, 1364-1371. (Pubitemid 47234313)
216. Weinreb, O.; Mandel, S.; Amit, T.; Youdim, M.B. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. J. Nutr. Biochem., 2004, 15, 506-516. (Pubitemid 39209392)
217. Ward, C.P.; Redd, K.; Williams, B.M.; Caler, J.R.; Luo, Y.; McCoy, J.G. Ginkgo biloba extract: Cognitive enhancer or antistress buffer. Pharmacol. Biochem. Behav., 2002, 72, 913-22. (Pubitemid 34621318)
218. Birks, J.; Evans, J.G. Intervention review: Ginkgo biloba for cognitive impairment and dementia. In: Cochrane Database of Systematic Reviews; Edited by Cochrane Dementia and Cognitive Improvement Group; John Wiley and Sons, Chichester, U.K.; 2009, 1, CD003120 (URL: Www.thecochranelibrary.com).
219. Le Bars, P.L.; Kieser, M.; Itil, K.Z. A 26-week analysis of a double-blind, placebo-controlled trial of the Ginkgo biloba extract EGb 761 in dementia. Dement. Geriatr. Cogn. Disord., 2000, 11, 230-237. (Pubitemid 30416029)
220. DeFeudis, F.V.; Drieu, K. Ginkgo biloba extract (EGb 761) and CNS functions: Basic studies and clinical applications. Curr. Drug Targets., 2000, 1, 25-58.
221. Pan, T.; Jankovic, J.; Le, W. Potential therapeutic properties of green tea polyphenols in Parkinson's disease. Drugs Aging., 2003, 20, 711-721. (Pubitemid 36995249)
222. Mandel, S.A.; Amit, T.; Weinreb, O.; Reznichenko, L.; Youdim, M.B. Simultaneous manipulation of multiple brain targets by green tea catechins: A potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS. Neurosci. Ther., 2008, 14, 352-365.
223. Mandel, S.A.; Amit, T.; Kalfon, L.; Reznichenko, L.; Weinreb, O.; Youdim, M.B. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: Special reference to epigallocatechin gallate (EGCG). J. Alzheimers Dis., 2008, 15, 211-222.
224. Mandel, S.A.; Amit, T.; Kalfon, L.; Reznichenko, L.; Youdim, M.B. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J. Nutr., 2008, 138, 1578S-1583S.
225. Singh, M.; Arseneault, M.; Sanderson, T.; Murthy, V.; Ramassamy, C. Challenges for research on polyphenols from foods in Alzheimer's disease: Bioavailability, metabolism, and cellular and molecular mechanisms. J. Agric. Food Chem., 2008, 56, 4855-4873. (Pubitemid 352039080)
226. Rezai-Zadeh, K.; Shytle, D.; Sun, N.; Mori, T.; Hou, H.; Jeanniton, D.; Ehrhart, J.; Townsend, K.; Zeng, J.; Morgan, D.; Hardy, J.; Town, T.; Tan, J. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci., 2005, 25, 8807-8814. (Pubitemid 41362059)
227. Rezai-Zadeh, K.; Arendash, G.W.; Hou, H.; Fernandez, F.; Jensen, M.; Runfeldt, M.; Shytle, R.D.; Tan, J. Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res., 2008, 1214, 177-187.
228. Lee, J.W.; Lee, Y.K.; Ban, J.O.; Ha, T.Y.; Yun, Y.P.; Han, S.B.; Oh, K.W.; Hong, J.T. Green tea (-)-epigallocatechin-3-gallate inhibits β-amyloidinduced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kB pathways in mice. J. Nutr., 2009, 139, 1987-1993.
229. Lee, Y.K.; Yuk, D.Y.; Lee, J.W.; Lee, S.Y.; Ha, T.Y.; Oh, K.W.; Yun, Y.P.; Hong, J.T. (-)-Epigallocatechin-3-gallate prevents lipopolysaccharideinduced elevation of beta-amyloid generation and memory deficiency. Brain Res., 2009, 1250, 164-174.
230. Haque, A.M.; Hashimoto, M.; Katakura, M.; Hara, Y.; Shido, O. Green tea catechins prevent cognitive deficits caused by A 1-40 in rats. J. Nutr. Biochem., 2008, 19, 619-626.
231. Scalbert, A.; Manach, C.; Morand, C.; Rémésy, C.; Jiménez, L. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr., 2005, 45, 287-306. (Pubitemid 41657352)
232. Neto, C.C. Cranberry and blueberry: Evidence for protective effects against cancer and vascular diseases. Mol. Nutr. Food Res., 2007, 51, 652-664. (Pubitemid 47083676)
233. Joseph, J.A.; Shukitt-Hale, B.; Denisova, N.A.; Bielinski, D.; Martin, A.; McEwen, J.J.; Bickford, P.C. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J. Neurosci., 1999, 19, 8114-8121. (Pubitemid 30225807)
234. Shukitt-Hale, B.; Lau, F.C.; Joseph, J.A. Berry fruit supplementation and the aging brain. J. Agric. Food Chem., 2008, 56, 636-641. (Pubitemid 351300224)
235. Zafra-Stone, S.; Yasmin, T.; Bagchi, M.; Chatterjee, A.; Vinson, J.A.; Bagchi, D. Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol. Nutr. Food Res., 2007, 51, 675-683. (Pubitemid 47083678)
236. Kang, S.S.; Lee, J.Y.; Choi, Y.K.; Song, S.S.; Kim, J.S.; Jeon, S.J.; Han, Y.N.; Son, K.H.; Han, B.H. Neuroprotective effects of naturally occurring biflavonoids. Bioorg. Med. Chem. Lett., 2005, 15, 3588-3591.
237. Luchsinger, J.A.; Noble, J.M.; Scarmeas, N. Diet and Alzheimer's disease. Curr. Neurol. Neurosci. Rep., 2007, 7, 366-372. (Pubitemid 47422777)
238. Checkoway, H.; Powers, K.; Smith-Weller, T.; Franklin, G.M.; Longstreth, J.; Swanson, P.D. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am. J. Epidemiol., 2002, 155, 732-738. (Pubitemid 34297653)
239. Tan, L.C.; Koh, W.P.; Yuan, J.M.; Wang, R.; Au, W.L.; Tan, J.H.; Tan, E.K.; Yu, M.C. Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese health study. Am. J. Epidemiol., 2008, 167, 553-560. (Pubitemid 351323310)
240. Datla, K.P.; Zbarsky, V.; Rai, D.; Parkar, S.; Osakabe, N.; Aruoma, O.I.; Dexter, D.T. Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson's disease. J. Am. Coll. Nutr., 2007, 26, 341-349. (Pubitemid 47579902)
241. McGuire, S.O.; Sortwell, C.E.; Shukitt-Hale, B.; Joseph, J.A.; Hejna, M.J.; Collier, T.J. Dietary supplementation with blueberry extract improves survival of transplanted dopamine neurons. Nutr. Neurosci., 2006, 9, 251-258. (Pubitemid 44970950)
242. Panickar, K.S.; Polansky, M.M.; Anderson, R.A. Green tea polyphenols attenuate glial swelling and mitochondrial dysfunction following oxygenglucose deprivation in cultures. Nutr. Neurosci., 2009, 12, 105-113.
243. Levites, Y.; Weinreb, O.; Maor, G.; Youdim, M.B.H.; Mandel, S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem., 2001, 78, 1073-1082. (Pubitemid 32823156)
244. Zbarsky, V.; Datla, K.P.; Parkar, S.; Rai, D.K.; Aruoma, O.I.; Dexter, D.T. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-hydroxydopamine model of Parkinson's disease. Free Rad. Res., 2005, 39, 1119-1125. (Pubitemid 41358566)
245. Kim, H.J.; Song, J.Y.; Park, H.J.; Park, H.K.; Yun, D.H.; Chung, J.H. Naringin protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Korean J. Physiol. Pharmacol., 2009, 13, 281-285.
246. Mercer, L.D.; Kelly, B.L.; Home, M.K.; Beart, P.M. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: Investigations in primary rat mesencephalic cultures. Biochem. Pharmacol., 2005, 69, 339-345. (Pubitemid 41556580)
247. Gagné, B.; Gélinas, S.; Bureau, G.; Lagacé, B.; Ramassamy, C.; Chiasson, K.; Valastro, B.; Martinoli, M.G. Effects of estradiol, phytoestrogens, and Ginkgo biloba extracts against 1-methyl-4-phenyl-pyridine- induced oxidative stress. Endocrine, 2003, 21, 89-95. (Pubitemid 36677348)
248. Vauzour, D.; Corona, G.; Spencer, J.P. Caffeic acid, tyrosol and p- coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity. Arch. Biochem. Biophys., 2010, 501, 106-111.
249. Gil, J.M.; Rego, A.C. Mechanisms of neurodegeneration in Huntington's disease. Eur. J. Neurosci., 2008, 27, 2803-2820. (Pubitemid 351832229)
250. Ehrnhoefer, D.E.; Duennwald, M.; Markovic, P.; Wacker, J.L.; Engemann, S.; Roark, M.; Legleiter, J.; Marsh, J.L.; Thompson, L.M.; Lindquist, S.; Muchowski, P.J.; Wanker, E.E. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Hum. Mol. Genet., 2006, 15, 2743-2751. (Pubitemid 44400401)
251. Lagoa, R.; Lopez-Sanchez, C.; Samhan-Arias, A.K.; Ganan, C.M.; Garcia- Martinez, V.; Gutierrez-Merino, C. Neuroprotective effect of kaempferol in the 3-nitropropionic acid model of Huntington's disease. Free Radic. Res., 2009, 43(S1), 71.
252. Kumar, P.; Kumar, A. Protective effect of hesperidin and naringin against 3- nitropropionic acid induced Huntington's like symptoms in rats: Possible role of nitric oxide. Behav. Brain Res., 2010, 206, 38-46.
253. Gomes, A.; Fernandes, E.; Lima, J.L.; Mira, L.; Corvo, M.L. Molecular mechanisms of anti-inflammatory activity mediated by flavonoids. Curr. Med. Chem., 2008, 15, 1586-1605.
254. Tuñon, M.J.; Garcia-Mediavilla, M.V.; Sanchez-Campos, S.; Gonzalez- Gallego, J. Potential of flavonoids as anti-inflammatory agents: Modulation of pro-inflammatory gene expression and signal transduction pathways. Curr. Drug Metab., 2009, 10, 256-271.
255. Muraoka, K.; Shimizu, K.; Sun, X.; Tani, Y.; Izumumi, R.; Miwa, K.; Yamamoto, K. Flavonoids exert diverse inhibitory effects on the activation of NF-kappaB. Transplant. Proc., 2002, 34, 1335-1340. (Pubitemid 34665355)
256. Nair, M.P.; Mahajan, S.; Reynolds, J.L.; Aalinkeel, R.; Nair, H.; Schwartz, S.A.; Kandaswami, C. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expresión in normal peripheral mononuclear cells via modulation of the NF-kappa beta system. Clin. Vaccine Immunol., 2002, 13, 319-328.
257. Cho, S.Y.; Park, S.J.; Kwon, M.J.; Jeong, T.S.; Bok, S.H.; Choi, W.Y.; Jeong, W.I.; Ryu, S.Y.; Do, S.H.; Lee, C.S.; Song, J.C.; Jeong, K.S. Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol. Cell. Biochem., 2003, 243, 153-160.
258. Chen, C.C.; Chow, M.P.; Huang, W.C.; Lin, Y.C.; Chang, Y.J. Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: Structure-activity relationships. Mol. Pharmacol., 2004, 66, 683-693.
259. Comalada, M.; Camuesco, D.; Sierra, S.; Ballester, I.; Xaus, J.; Gálvez, J.; Zarzuelo, A. In vivo quercetina anti-inflammatory effect involves releases of quercetina, which inhibits inflammation through down-regulation of NFkappaB pathway. Eur. J. Immunol., 2005, 35, 584-592. (Pubitemid 40331335)
260. Kim, J.S.; Jobin, C. The flavonoid luteolin prevents lipopolysaccharideinduced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology, 2005, 115, 375-387. (Pubitemid 40896036)
261. Longpré, F.; Garneau, P.; Christen, Y.; Ramassamy, C. Protection by EGb 761 against beta-amyloid-induced neurotoxicity: Involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation. Free Radic. Biol. Med., 2006, 41, 1781-1794. (Pubitemid 44848398)
262. Nicholas, C.; Batra, S.; Vargo, M.A.; Voss, O.H.; Gavrilin, M.A.; Wewers, M.D.; Guttridge, D.C.; Grotewold, E.; Doseff, A.I. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J Immunol., 2007, 179, 7121-7127.
263. Kim, J.H.; Lee, G.; Cho, Y.L.; Kim, C.K.; Han, S.; Lee, H.; Choi, J.S.; Choe, J.; Won, M.H.; Kwon, Y.G.; Ha, K.S.; Kim, Y.M. Desmethylanhydroicaritin inhibits NF-kappaB-regulated inflammatory gene expression by modulating the redox-sensitive PI3K/PTEN/Akt pathway. Eur J Pharmacol., 2009, 602, 422-431.
264. Kang, O.H.; Choi, J.G.; Lee, J.H.; Kwon, D.Y. Luteolin isolated from the flowers of Lonicera japonica suppresses inflammatory mediator release by blocking NF-kappaB and MAPKs activation pathways in HMC-1 cells. Molecules, 2010, 15, 385-398.
265. Li, X.; Huang, Q.; Ong, C.N.; Yang, X.F.; Shen, H.M. Chrysin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells via suppression of nuclear factor-kappaB. Cancer Lett., 2010, 293, 109-116.
266. Parajuli, P.; Joshee, N.; Chinni, S.R.; Rimando, A.M.; Mittal, S.; Sethi, S.; Yadav, A.K. Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NF-kappaB signaling. Neurooncology, 2011, 101, 15-24.
267. Genestra, M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal., 2007, 19(9), 1807-1819. (Pubitemid 47090178)
268. Zhang, J.; Johnston, G.; Stebler, B.; Keller, E.T. Hydrogen peroxide activates NFkappaB and the interleukin-6 promoter through NFkappaB-inducing kinase. Antioxid. Redox Signal., 2001, 3, 493-504. (Pubitemid 32646039)
269. Gloire, G.; Legrand-Poels, S.; Piette, J. NF-kappaB activation by reactive oxygen species: Fifteen years later. Biochem. Pharmacol., 2006, 72, 1493-1505. (Pubitemid 44666727)
270. Gloire, G.; Piette, J. Redox regulation of nuclear post-translational modifications during NF-kappaB activation. Antioxid Redox Signal., 2009, 11, 2209-2222.
271. Xagorari, A.; Roussos, C.; Papapetropoulos, A. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. Br. J. Pharmacol., 2002, 136, 1058-1064.
272. Yoshizumi, M.; Abe, J.; Haendeler, J.; Huang, Q.; Berk, B.C. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J. Biol. Chem., 2000, 275, 11706-11712. (Pubitemid 30237733)
273. Middleton, E.; Kandaswami, C.; Theoharides, T.C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer. Pharmacol. Rev., 2000, 52, 673-751.
274. Rimbach, G.; Saliou, C.; Panali, R.; Virgili, F. Interaction between cultured endothelial cells and macrophages in vitro model for studying flavonoids in redox dependent gene expression. Methods Enzymol., 2001, 335, 387-397. (Pubitemid 32509600)
275. Weber, C.; Erl, W.; Pietsch, A.; Srobel, M.; Ziegler-Heitbrock, H.W.L.; Weber, P.C. Antioxidants inhibit monocyte adhesion by supressing nuclear factor-kappaB mobilization and induction of vascular cell adhesion molecule- 1 in endothelial cells stimulated to generate radicals. Arterioscler. Thromb., 1994, 14, 1665-1673.
276. Wolle, J.; Hill, R.R.; Ferguson, E.; Devall, L.J.; Trivedi, B.K.; Newton, R.S.; Saxena, U. Selective inhibition of tumor necrosis factor-induced vascular cell adhesion molecule-1 gene expression by a novel flavonoid. Arterioscler. Thromb. Vasc. Biol., 1996, 16, 1501-1508.
277. Stangl, V.; Lorenz, M.; Ludwig, A.; Gimbo, N.; Guether, C.; Sanad, W.; Ziemer, S.; Martus, P.; Baumann, G.; Stangl, K. The flavonoid phloretin suppresses stimulated expression of endothelial adhesion molecules and reduces activation of human platelets. J. Nutr., 2005, 135, 172-179.
278. Pace-Asciak, C.R.; Hahn, S.; Diamandis, E.P.; Soleas, G.; Goldberg, D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation in eicosanoid synthesis: Implication for protection against coronary heart disease. Clin. Chim. Acta., 1995, 23, 207-219.
279. Dutta-Roy, A.K. Dietary components and human platelet activity. Platelets, 2002, 13, 67-75. (Pubitemid 34407247)
280. Hubbard, G.P.; Wolffram, S.; Lovegrove, J.A.; Gibbins, J.M. The role of polyphenolic compounds in the diet as inhibitors of platelet function. Proc. Nutr. Soc., 2003, 62, 469-478. (Pubitemid 36841622)
281. Hubbard, G.P.; Wolffram, S.; Lovegrove, J.A.; Gibbins, J.M. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen- stimulated platelet activation pathway in humans. J. Thromb. Haemost., 2004, 2, 2138-2145. (Pubitemid 40185773)
282. Guerrero, J.A.; Lozano, M.L.; Castillo, J.; Benavente-García, O.; Vicente, V.; Rivera, J. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J. Thromb. Haemost., 2005, 3, 369-376. (Pubitemid 41623628)
283. Nardini, M.; Natella, F.; Scaccini, C. Role of dietary polyphenols in platelet aggregation. A review of the supplementation studies. Platelets, 2007, 18, 224-243. (Pubitemid 46744120)
284. Arthur, J.F.; Gardiner, E.E.; Kenny, D.; Andrews, R.K.; Berndt, M.C. Platelet receptor redox modulation. Platelets, 2008, 19, 1-8.
285. Ostertag, L.M.; O'Kennedy, N.; Kroon, P.A.; Duthie, G.G.; de Roos, B. Impact of dietary polyphenols on human platelet function, a critical review of controlled dietary intervention studies. Mol. Nutr. Food. Res., 2010, 54, 60-81.
286. Tikkanen, M.J.; Wahaia, K.; Ojala, S.; Viluma, V.; Adlercreutz, H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc. Natl. Acad. Sci. USA, 1998, 95, 3106-3110. (Pubitemid 28135862)
287. Meydany, M. Nutrition interventions in aging and age-associated disease. Ann. N.Y. Acad. Sci., 2001, 928, 226-235.
288. Olszanecki, R.; Gebska, A.; Kozioovski, V.I.; Gryglewski, R.J. Flavonoids and nitric oxide synthase. J. Physiol. Pharmacol., 2002, 53, 571-584. (Pubitemid 36014803)
289. Robak, J.; Shridi, F.; Wolbis, M.; Krolikowska, M. Screening of the influence of flavonoids on lypooxygenase and ciclooxygenase activity, as well as non-enzymatic lipid oxidation. Pol. J. Pharmacol. Pharm., 1988, 40, 451-458.
290. File, S.E.; Jarrett, N.; Fluck, E.; Duffy, R.; Casey, K.; Wiseman, H. Eating soya improves human memory. Psychopharmacology, 2001, 157, 430-436. (Pubitemid 32988491)
291. Graves, A.B.; Larson, E.B.; White, L.R.; Teng, E.L.; Homma, A. Crosscultural research and perspectives: Opportunities and challenges in international collaborative epidemiologic research of dementia and its subtypes. Studies between Japan and the USA. Int. Psychogeriatr., 1994, 6, 209-223. (Pubitemid 24361665)
292. Yoshitake, T.; Kiyohara, Y.; Kato, I.; Ohmura, T.; Iwamoto, H.; Nakayama, K.; Ohmori, S.; Nomiyama, K.; Kawano, H.; Ueda, K. Incidencie and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology, 1995, 45, 1161-1168.
293. Kobayashi, Y.; Suzuki, M.; Satsu, H.; Arai, S.; Hara, H.; Suzuki, K.; Miyamoto, Y.; Shimizu, M. Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J. Agric. Food Chem., 2000, 48, 5618-5623.
294. Dulloo, A.G.; Duret, C.; Rohrer, G.L.; Mensi, N.; Fathi, M.; Chantre, P.; Vandermander, J. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am. J. Clin. Nutr., 1999, 70, 1040-1045.
295. Johnston, K.; Sharp, P.; Clifford, M.; Morgan, L. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett., 2005, 579, 1653-1657. (Pubitemid 40341538)
296. Kao, Y.H.; Hiipakka, R.A.; Liao, S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology, 2000, 141, 980-987. (Pubitemid 32260441)
297. Jung, U.J.; Lee, M.K.; Jeong, K.S.; Choi, M.S. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose regulating enzymes in C57BL/KsJ-db/db mice. J. Nutr., 2004, 134, 2499-2503. (Pubitemid 39315245)
298. Temme, E.H.; van Hoydonck, P.G. Tea consumption and iron status. Eur. J. Clin. Nutr., 2002, 56, 379-386. (Pubitemid 34525060)
299. Van der Heide, D.; Kasteljin, J.; Schroeder-van der Elst, J.P. Flavonoids and thyroid disease. Biofactors, 2003, 19, 113-119. (Pubitemid 38175114)
300. Messina, M.; Redmond, G. Effects of soy protein and soybean isoflavones on thyroid function in healthy adults and hypothyroid patients: A review of the relevant literature. Thyroid, 2006, 16, 249-258.
301. Horn-Ross, P.L.; Hoggatt, K.J.; Lee, M.M. Phytoestrogens and thyroid cancer risk: The San Francisco Bay Area thyroid cancer study. Cancer Epidemiol. Biomarkers Prev., 2002, 11, 43-49. (Pubitemid 34118312)
302. Kimura, S.; Suwa, J.; Ho, M.; Sato, H. Development of malignant goitier by defatted soybean with iodine-free diet in rats. Gann, 1976, 67, 763-765.
303. Soy, H.Y.; Nishikawa, A.; Ikeda, T.; Furukawa, F.; Hirose, M. Lack of modification by environmental estrogenic compounds of thyroid carcinogenesis in ovariectomized rats pretreated with N-bis(2- hydroxypropylnitrosaine) (DHPN). Jpn. J. Cancer Res., 2000, 91, 966-972.
304. Strom, B.L.; Schinnar, R.; Ziegler, E.E.; Barnhart, K.T.; Samuel, M.D.; Macones, G.A.; Stallings, V.A.; Drulis, J.M.; Nelson, S.E.; Hanson, S.A. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. JAMA, 2001, 286, 807-814. (Pubitemid 33015574)
305. Anthony, M.S.; Clarkson, T.B.; Hughes, C.L.; Morgan, T.M.; Burke, G.L. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripuberal rhesus monkeys. J. Nutr., 1996, 126, 43-50. (Pubitemid 26030632)
306. Zhu, B.T.; Liebr, J.G. Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol. Appl. Pharmacol., 1994, 125, 149-158. (Pubitemid 24104464)
307. Mennen, L.I.; Walker, R.; Benneteau-Pelissero, C.; Scalbert, A. Risks and safety of polyphenols consumption. Am. J. Clin. Nutr., 2005, 81, S326-S329.
308. Veronese, M.L.; Gillen, L.P.; Burke, J.P.; Eorval, E.P.; Hauck, W.W.; Pequignot, E.; Waldman, S.A.; Greenberg, H.E. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice. J. Clin. Pharmacol., 2003, 43, 831-839. (Pubitemid 36886103)
309. Galati, G.; O'Brien, P.J. Potential toxicity of flavonoids and other dietary phenolics: Significance of their chemopreventive and anticancer properties. Free Radic. Biol. Med., 2004, 37, 287-303. (Pubitemid 38833996)
310. Tsukamoto, S.; Tomise, K.; Aburatan, M.; Onuki, H.; Hirorta, H.; Ishiharajima, E.; Ohta, T. Isolation of cytochrome P450 inhibitors from strawberry fruit, Fragaria ananassa. J. Nat. Prod., 2004, 67, 1839-1841. (Pubitemid 39602361)
311. Strick, R.; Strissel, P.L.; Borgers, S.; Smith, S.L.; Rowley, L.D. Dietary bioflavonoids induce cleavage in the MLL gene and may contribuye to infant leucemia. Proc. Natl. Acad. Sci. USA., 2000, 97, 4790-4795. (Pubitemid 30238636)
312. Hooper, L.; Kroon, P.A.; Rimm, E.B.; Cohn, J.S.; Harvey, I.; Le Cornu, K.A.; Ryder, J.J.; Hall, W.L.; Cassidy, A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr., 2008, 88, 38-50. (Pubitemid 351988681)
313. Grassi, D.; Desideri, G.; Croce, G.; Tiberti, S.; Aggio, A.; Ferri, C. Flavonoids, vascular function and cardiovascular protection. Curr. Pharm. Des., 2009, 15, 1072-1084.
314. Hollman, P.C.; Geelen, A.; Kromhout, D. Dietary flavonol intake may lower stroke risk in men and women. J. Nutr., 2010, 140, 600-604.
315. Leonarduzzi, G.; Testa, G.; Sottero, B.; Gamba, P.; Poli, G. Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids. Curr. Med. Chem., 2010, 17, 74-95.